Delivery Order SPE2DB20D1102-SPE2DB25FC6BU

Award Date 3/13/25
Potential Completion Date 3/14/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the supply of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,645.33 delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,757.24 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,486.46 firm-fixed-price delivery order contract is for the supply of 4,567,299,122 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,542.74 firm fixed-price delivery order is for the provision of 100 capsules of the medication Vyvanse 30 mg. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Vyvanse 30mg capsules to the Defense Logistics Agency (DLA). The $1,210.36 firm fixed-price contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,148.69 firm fixed price delivery order is for the supply of 20 mg Vyvanse capsules in 100-count bottles. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a broad range of pharmaceutical...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,074.09 for the delivery of Vyvanse 30 mg capsules to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract is a Firm Fixed Price Delivery Order with a completion date of November 27, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA to supply a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Vyvanse 60 mg capsules to the Defense Logistics Agency (DLA). The $2,164.76 firm fixed-price delivery order, with a completion date of March 14, 2025, is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Vyvanse 40 mg capsules. The $5,760.64 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract has an ultimate completion date of September 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $8,454.05 for the supply of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB25FC6BU
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA). The $3,381.61 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This specific delivery order has an ultimate completion date of March 14, 2025. The contract award does not have a set-aside designation, indicating open competition.

Generated 6/12/25, 10:06 AM